Partnering with Aspreva

WORKING TOGETHER TO PROVIDE OPTIONS FOR PATIENTS

In an indication partnership, Aspreva gains access to the product and provides the funding, human resources, and clinical and regulatory development responsibilities, and commercial strategy of developing the product for the new indication. For our partners, the collaboration grants access to Aspreva's expertise in drug development and commercialization for complex less common diseases.

Indication Partnering allows our pharmaceutical partners to:

• Maintain control of their product
• Protect and focus on the product's core franchise
• Maximize full value potential of the product, financially and clinically
• Achieve risk-reduced incremental sales growth
• Minimize resource requirements for additional indication(s)
• Demonstrate corporate commitment to identifying treatments for less common diseases

The pharmaceutical industry is embracing this unique business model that can unlock value from existing products. Aspreva is the strategic partner that can effectively reach new markets and enhance the lifecycle of a brand.

Aspreva Partnering Models
While "Indication Partnering" represents Aspreva's core collaboration model, potential partnering companies are encouraged to contact us at BD@aspreva.com to discuss a unique opportunity. Consistent with Aspreva's flexibile partnering approach and commitment to providing treatments to patients living with less common diseases, we welcome collaboration ideas that can help meet the needs of these patients.